ASX:PYC (Australia)  
PYC Therapeutics Ltd logo

PYC Therapeutics Ltd

A$ 0.07 (-4.41%) Dec 9
P/E:
At Loss
P/B:
5.67
Market Cap:
A$ 216.30M ($ 146.97M)
Enterprise V:
A$ 188.14M ($ 127.84M)
Volume:
228.50K
Avg Vol (2M):
397.49K
Also Trade In:
Volume:
228.50K
Market Cap A$:
216.30M
Market Cap $:
146.97M
PE Ratio:
At Loss
Avg Vol (2-Month):
397.49K
Enterprise Value A$:
188.14M
Enterprise Value $:
127.84M
PB Ratio:
5.67

Business Description

Description
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the major challenge in RNA therapeutics - safe and effective delivery of the drug inside the cell. Geographically, it operates only in Australia.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 30.84
Equity-to-Asset 0.87
Debt-to-Equity 0.02
Debt-to-EBITDA -0.07
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score 99999999.99
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 7.19
9-Day RSI 21.9
14-Day RSI 32.77
6-1 Month Momentum % 1.32
12-1 Month Momentum % -45

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.94
Quick Ratio 8.94
Cash Ratio 6.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.4

Profitability Rank

Name Current Vs Industry Vs History
ROE % -29.98
ROA % -26.81
ROIC % -341.31
ROC (Joel Greenblatt) % -970.8
ROCE % -29.77